Tower Research Capital (TRC)’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-6,516
| Closed | -$9.45K | – | 5387 |
|
2025
Q1 | $9.45K | Buy |
6,516
+174
| +3% | +$252 | ﹤0.01% | 3776 |
|
2024
Q4 | $13.1K | Buy |
6,342
+650
| +11% | +$1.35K | ﹤0.01% | 3556 |
|
2024
Q3 | $10K | Buy |
5,692
+547
| +11% | +$963 | ﹤0.01% | 3813 |
|
2024
Q2 | $74.4K | Buy |
5,145
+4,600
| +844% | +$66.5K | ﹤0.01% | 2800 |
|
2024
Q1 | $9.06K | Sell |
545
-1,911
| -78% | -$31.8K | ﹤0.01% | 3906 |
|
2023
Q4 | $39.4K | Sell |
2,456
-82
| -3% | -$1.32K | ﹤0.01% | 3280 |
|
2023
Q3 | $34.1K | Buy |
2,538
+150
| +6% | +$2.02K | ﹤0.01% | 2910 |
|
2023
Q2 | $41K | Sell |
2,388
-199
| -8% | -$3.42K | ﹤0.01% | 2733 |
|
2023
Q1 | $43K | Buy |
2,587
+943
| +57% | +$15.7K | ﹤0.01% | 2636 |
|
2022
Q4 | $28K | Buy |
1,644
+1,045
| +174% | +$17.8K | ﹤0.01% | 2809 |
|
2022
Q3 | $10K | Sell |
599
-1,773
| -75% | -$29.6K | ﹤0.01% | 4537 |
|
2022
Q2 | $26K | Buy |
+2,372
| New | +$26K | ﹤0.01% | 3511 |
|